Investment Stage

Focus Areas

About Investor

Tatiana Shalalvand is an Investment Director at Kinnevik and is based in Stockholm. She focuses on healthcare services, AI, and BioTech companies from the Seed stage through Series B. Her investment work follows founders applying scientific innovation and intelligent technology to improve healthcare delivery, research, diagnostics, and patient outcomes. Tatiana typically invests between $3M and $30M, with a preferred ticket of approximately $15M. As a lead investor, she contributes actively to company selection, due diligence, financing strategy, and portfolio support. At Kinnevik, she helps health and life-science companies progress from early validation toward meaningful commercial scale.